OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Screening for Colorectal Cancer	60
Epidemiology of Melanoma	58
Biology of Melanoma	52
Diagnosis and Staging of Bladder Cancer	46
Factor XI Deficiency	46
The Epidemiology of Bladder Cancer	30
Lip and Oral Cavity Squamous Cell Carcinoma	30
Colorectal Cancer in Younger Adults	26
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus	25
Von Willebrand Disease	24
Hereditary Colorectal Cancer	23
Overview of Myeloproliferative Neoplasms	23
Disorders of Fibrinogen and Fibrinolysis	21
Gene Therapy for Hemoglobinopathies	18
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	17
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms	17
The Epidemiology of Central Nervous System Tumors	17
Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)	16
Genetics of Myeloproliferative Neoplasms	15
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	15
Pancreatic Adenocarcinoma	15
The Role of Megakaryocytes in Myelofibrosis	15
Acquired Hemophilia A	15
Structural Racism and Impact on Sickle Cell Disease	15
Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia	14

The Microenvironment in Myeloproliferative Neoplasms	14
Primary Central Nervous System Lymphomas	13
Developing Precision Medicine for Bladder Cancer	13
Acquired von Willebrand Syndrome	13
Immunotherapy for Head and Neck Cancer	13
Impact of Diet and Exercise on Colorectal Cancer	12
Cancer of the Paranasal Sinuses	11
Current Clinical Investigations in Myelofibrosis	11
Systemic Amyloidosis Due to Clonal Plasma Cell Diseases	11
Gene Therapy and Gene Editing for β-Thalassemia	11
Go the Distance	11
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors	11
Preclinical Models for Bladder Cancer Research	10
A Curative DNA Code for Hematopoietic Defects	10
Factor XIII Deficiency	10
Central Nervous System Metastases	10
Cellular Therapy and Cytokine Treatments for Melanoma	10
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer	9
Evolution of Gene Therapy, Historical Perspective	9
Cancer of the Larynx and Hypopharynx	9
Renal Cell Carcinoma of Variant Histology	9
Update on Radiation Therapy for Central Nervous System Tumors	9
The Process of Amyloid Formation due to Monoclonal Immunoglobulins	9
Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis	9
Managing Recurrent Metastatic Head and Neck Cancer	9
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?	9
Systemic Amyloidosis due to Low-Grade Lymphoma	9
Adult Evans' Syndrome	8
Management of Rectal Cancer	8
Biology and Treatment of HER2-Low Breast Cancer	8
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	8
Quality of Life in Sickle Cell Disease	8
Salivary Gland Cancers	8
Neurofibromatoses	8
Hemophilia B (Factor IX Deficiency)	8
The Clinical Phenotypes of Alpha Thalassemia	8
Quality of Life in Myeloproliferative Neoplasms	8
Hemophilia A (Factor VIII Deficiency)	8
Monoclonal Antibody Therapies in Systemic Light-Chain Amyloidosis	8
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms	8
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer	7
Molecular Basis and Genetic Modifiers of Thalassemia	7
Fetal Hemoglobin Regulation in Beta-Thalassemia	7
Breast Cancer and Lifestyle Factors	7
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia	7
Real World Outcomes of Patients with Bladder Cancer	7
Robotic and Endoscopic Approaches to Head and Neck Surgery	7
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	7
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology	6
Imaging Advances for Central Nervous System Tumors	6

Gene Therapy for Inborn Errors of Immunity	6
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	6
Application of Stem Cell Therapy in Myelofibrosis	6
Combinatorial Approaches to the Treatment of Advanced Melanoma	6
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	6
Hematopoietic Stem Cell Transplantation in Thalassemia	6
Chimeric Antigen Receptor T-cell Therapy	6
Liver and Gastrointestinal Involvement	6
Immune Therapy for Chronic Lymphocytic Leukemia	6
Immunotherapy-associated Autoimmune Hemolytic Anemia	6
Molecular Biology of Bladder Cancer	6
Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	5
Is There a Role for Immunotherapy in Central Nervous System Cancers?	5
Disparities and Inequities Among Patients with Central Nervous System Tumor	5
Hereditary Renal Cell Carcinoma Syndromes	5
Current Therapy for Metastatic Urothelial Carcinoma	5
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	5
Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia	5
Lung Cancer Supportive Care and Symptom Management	5
Advanced Melanoma	5
Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers	5
Liver and Gastrointestinal Involvement	5
Genetics of Pancreatic Neuroendocrine Tumors	5
Accelerated and Blast Phase Myeloproliferative Neoplasms	5
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia	5
State of Melanoma	5
Nonoperative Management for Rectal Cancer	5
Cancer of the Oropharynx and the Association with Human Papillomavirus	5
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art	5
Systemic Amyloidosis due to Monoclonal Immunoglobulins	4
The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia	4
Future Perspectives	4
Epigenetic Dysregulation of Myeloproliferative Neoplasms	4
Emerging Targeted Therapy for Bladder Cancer	4
Evidence-Based Guidance for Breast Cancer Survivorship	4
Chronic Pain	4
Renal Involvement in Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	4
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	4
Central Nervous System Complications Among Oncology Patients	4
Role of Ovarian Suppression in Early Premenopausal Breast Cancer	4
Clinical Challenges with Iron Chelation in Beta Thalassemia	4
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer	4
Red Cell Antigens and Antibodies	4
Emerging Therapies in β-Thalassemia	4
Pathogenic Mechanisms in Thalassemia I	4
Surgery for Bladder and Upper Tract Urothelial Cancer	4
Supportive Care for Patients with Systemic Light Chain Amyloidosis	4
Immune Checkpoint Therapies for Melanoma	4
DAT-Negative Autoimmune Hemolytic Anemia	4
Biology and Treatment of Meningiomas	4
Surgical Management of the Axilla for Breast Cancer	4
Extracutaneous Melanoma	4
Cytotoxic Chemotherapy in Advanced Pancreatic Cancer	4
The Gut Microbiome in Colorectal Cancer	4
Disparities in Breast Cancer Outcomes and How to Resolve Them	4
The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes	4
Genetic Modifiers of Sickle Cell Disease	4